BIOCRATES Life Sciences AG to Launch Thermo Edition of its State-of-the-art Metabolomics-based Research Kit, AbsoluteIDQ® p150

News provided by

BIOCRATES Life Sciences AG

27 Feb, 2013, 09:00 ET

INNSBRUCK, Austria, February 27, 2013 /PRNewswire/ --

Austrian BIOCRATES Life Sciences AG, prime developer of cutting-edge metabolite metabolomics products, is about to launch the next edition of its well-established research kit, AbsoluteIDQ® p150, for use with Thermo Scientific's TSQ Vantage Triple Stage Quadrupole Mass Spectrometer.

BIOCRATES Life Sciences announces the launch of a new edition of its well-established research kit, AbsoluteIDQ® p150. The kit, which has been available for use with AB Sciex and Waters mass spectrometry systems, has now been designed to also run on Thermo Scientific's TSQ Vantage Triple Stage Quadrupole Mass Spectrometer, enabling even more research labs to harness the power of targeted metabolite quantification based on a ready-to-use kit system. Combined with a robust new ion source, second-generation ion optics and hyperbolic quadrupoles, the Thermo Scientific TSQ Vantage delivers the highest sensitivity with the lowest chemical noise.

AbsoluteIDQ p150 provides extensive metabolic information from a single targeted assay, quantifying 158 metabolites using a FIA-MS/MS method. It features the proprietary MetIDQ™ software, requires minute sample volumes (10 µL), and is suitable for use with a wide range of biological samples, making it an excellent choice for researchers looking for a cost-effective solution to measure endogenous metabolites under quality-controlled conditions in their own lab. The AbsoluteIDQ kits by BIOCRATES have been successfully applied in many different areas, including diabetes, nephrology, sepsis, and CNS disorders, in both clinical and pharmaceutical research.

About BIOCRATES

BIOCRATES Life Sciences AG is a leading biotechnology company focused on the development of metabolomics products as well as in vitro diagnostics (IVDs) for early disease and progression detection in areas such as nephrology, diabetes, oncology, and endocrinology. Our mass spectrometry-based, standardized metabolomic kits and IVDs provide unprecedented accuracy, precision, and multiplexing potential that will help revolutionize the way personalized medicine is applied in R&D and diagnostics.

Please also visit us at http://www.biocrates.com.
BIOCRATES Life Sciences AG
Martina Klocker
[email protected]
Tel. +43(0)512-579823

SOURCE BIOCRATES Life Sciences AG

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.